scispace - formally typeset
Book ChapterDOI

Deep Brain Stimulation: Ethical Issues in Clinical Practice and Neurosurgical Research

TLDR
In this paper, the authors focus on the various ethical issues related to the clinical application and research of deep brain stimulation, and apply the proper ethical frame against which to evaluate the risks and benefits of neuromodulation, and determine whether a procedure constitutes established therapy or remains investigational.
Abstract
Publisher Summary This chapter focuses on the various ethical issues related to the clinical application and research of deep brain stimulation. DBS is recognized as therapeutic for the management of chronic pain, the evaluation and management of epilepsy, and the treatment of Parkinson's disease and other movement disorders. The Food and Drug Administration (FDA) has also approved the use of the deep brain stimulator for refractory Parkinson's disease and essential tremor in 1997. Clinical investigators are conducting trials for its use in obsessive–compulsive disorders, which awaits FDA approval, depression, and traumatic brain injury. The boundary between experimental work and therapeutic deployment rests on FDA approval of the device and the consensus of the medical community that the putative treatment is effective and safe and that the intended beneficial outcome will appear without adverse long or short-term effects. To apply the proper ethical frame against which to evaluate the risks and benefits of neuromodulation, it is necessary to determine whether a procedure constitutes established therapy or remains investigational. Determining this distinction is critical or else the investigator or clinician can inadvertently mislead a potential research participant or patient about the safety and efficacy of an intervention. A therapeutic misconception can also have its origins in the hopes and desperation of a patient eager for cure or in the manner within which consent is obtained for enrollment in a clinical trial. Usually, these misperceptions stem from both a combination of hope and hype, which may or may not be intended on the part of the investigator.

read more

Citations
More filters
Journal ArticleDOI

Deep brain stimulation, neuroethics, and the minimally conscious state: moving beyond proof of principle.

TL;DR: In the study, a severely brain-injured human subject showed behavioral improvements in attentive responsiveness, limb control, recovery of oral feeding, and spoken language following central thalamic DBS.
Journal ArticleDOI

Deep Brain Stimulation in Parkinsonian Patients—Ethical Evaluation of Cognitive, Affective, and Behavioral Sequelae

TL;DR: In this paper, the authors classify the effects of subthalamic nucleus DBS on the patient's quality of life and propose guidelines for the clinical setting of STN DBS.
Book ChapterDOI

Clinical pragmatism and the care of brain damaged patients: toward a palliative neuroethics for disorders of consciousness.

TL;DR: It is suggested that some of the resistance might be tempered if the needs of patients with severe brain injury are viewed through the prism of palliative care and adopt that field's ethos and methods when caring for and conducting research on individuals withsevere brain damage and disorders of consciousness.
Journal Article

Conflicts of interest in deep brain stimulation research and the ethics of transparency.

TL;DR: Ethical challenges faced in clinical research involving medical devices and cautionary notes about its funding and the interplay of market forces and scientific inquiry are described and some reforms are suggested.
Journal ArticleDOI

Sociology of Low Expectations: Recalibration as Innovation Work in Biomedicine.

TL;DR: It is argued that recalibration enables clinicians to manage the tension between the highly optimistic and hyped visions of the future that surround novel biomedical interventions, and the exigencies of delivering those interventions in a clinical setting.
References
More filters
Journal ArticleDOI

Equipoise and the ethics of clinical research.

TL;DR: An alternative concept of equipoise is suggested, which would be based on present or imminent controversy in the clinical community over the preferred treatment, which is satisfied if there is genuine uncertainty within the expert medical community--not necessarily on the part of the individual investigator--about the preferredreatment.
Journal ArticleDOI

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

TL;DR: Bilateral stimulation of the subthalamic nucleus or pars interna of the globus pallidus is associated with significant improvement in motor function in patients with Parkinson's disease whose condition cannot be further improved with medical therapy.
Journal ArticleDOI

Surgery in the Rat during Electrical Analgesia Induced by Focal Brain Stimulation

TL;DR: It was concluded that focal brain stimulation in this region can induce analgesia in the absence of diffusely applied "whole brain" stimulation.
Journal ArticleDOI

Behavioural improvements with thalamic stimulation after severe traumatic brain injury

TL;DR: It is shown that bilateral deep brain electrical stimulation of the central thalamus modulates behavioural responsiveness in a patient who remained in MCS for 6 yr followingtraumatic brain injury before the intervention, providing evidence that DBS can promote significant late functional recovery from severe traumatic brain injury.
Journal ArticleDOI

Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder

TL;DR: Predictive long-term effects of DBS in highly treatment-resistant OCD improved, as did self-care, independent living, and work, school, and social functioning, and depression and anxiety also improved.
Related Papers (5)